Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

BIODEXA PHARMACEUTICALS PLC

Company number 09216368

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
19 Jul 2023 SH02 Sub-division of shares on 14 June 2023
18 Jul 2023 SH08 Change of share class name or designation
11 Jul 2023 SH01 Statement of capital following an allotment of shares on 15 June 2023
  • GBP 5,277,806.44
07 Jul 2023 AA Group of companies' accounts made up to 31 December 2022
30 Jun 2023 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Company business/ appointment of director/ appointment of auditors 14/06/2023
  • RES10 ‐ Resolution of allotment of securities
30 Jun 2023 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES01 ‐ Resolution of adoption of Articles of Association
30 Jun 2023 MA Memorandum and Articles of Association
26 Jun 2023 SH01 Statement of capital following an allotment of shares on 6 June 2023
  • GBP 5,277,181.44
23 Jun 2023 SH01 Statement of capital following an allotment of shares on 26 May 2023
  • GBP 5,147,181.44
23 Jun 2023 SH01 Statement of capital following an allotment of shares on 9 May 2023
  • GBP 2,933,589.24
17 May 2023 MA Memorandum and Articles of Association
03 May 2023 SH01 Statement of capital following an allotment of shares on 19 April 2023
  • GBP 2,892,589.24
27 Apr 2023 SH01 Statement of capital following an allotment of shares on 30 March 2023
  • GBP 1,819,898.74
03 Apr 2023 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES12 ‐ Resolution of varying share rights or name
  • RES01 ‐ Resolution of adoption of Articles of Association
03 Apr 2023 SH02 Consolidation of shares on 27 March 2023
28 Mar 2023 SH01 Statement of capital following an allotment of shares on 24 March 2023
  • GBP 1,173,347.74
27 Mar 2023 CERTNM Company name changed midatech pharma PLC\certificate issued on 27/03/23
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2023-03-24
16 Feb 2023 SH01 Statement of capital following an allotment of shares on 15 February 2023
  • GBP 1,173,347.738
06 Feb 2023 SH01 Statement of capital following an allotment of shares on 19 December 2022
  • GBP 1,108,343.738
25 Jan 2023 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
27 Oct 2022 CS01 Confirmation statement made on 23 October 2022 with no updates
11 Oct 2022 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
27 Jun 2022 AP01 Appointment of Dr Stephen Barry Parker as a director on 20 June 2022
27 Jun 2022 TM01 Termination of appointment of Rolf Stahel as a director on 20 June 2022
24 Jun 2022 AA Group of companies' accounts made up to 31 December 2021